About Remodulin | Risks and Benefits

Drug Index: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

	Post Remodulin Side Effect Reporting Your Remodulin side effect will help others recognize and deal with Remodulin side effects.
	Ask Community Ask patient community about Remodulin related health issues.
	Recent Reports View Remodulin reports recently posted by other patients.
	FDA Remodulin Reports Learn about Remodulin adverse events reported to FDA.

Remodulin

News Aggregator

Aggregates results from the best known news search sites (Google, Yahoo, and, Microsoft(Live) )... These sites searches alllllllllllllllllllllllllllllllllll the news sites available, efficiently... Fetches news simultaneously by running parallel threads... Sorts the news based on publication date of the news(latest first)...

Revenues, however, increased 25.3% from the year-ago period. The Quarter in Detail Net product revenues, consisting of Remodulin, Tyvaso, Adcirca and other sales, increased 18.9% to $194.3 million in the reported quarter. Revenues increased primarily due ...

United Therapeutics Corporation ( UTHR) is facing a patent challenge for its lead product, Remodulin (treprostinil) injection. Sandoz, Novartis' ( NVS) generic unit, is seeking approval for its generic version of Remodulin (10 mg/mL). The Paragraph IV ...

The Paragraph IV Certification Notice Letter was received from Sandoz on Feb 3, 2012. Sandoz has filed an Abbreviated New Drug Application (:ANDA) with the US Food and Drug Administration (:FDA) for its generic version of Remodulin. Sandoz is ...

Shares of United Therapeutics Corp. (NASDAQ: UTHR) are lower in early action Tuesday after an analyst at Deutsche Bank highlighted that Sandoz has filed an ANDA to make generic remodulin. The firm notes that "Sandoz states it intends to market a generic ...

United Therapeutics Corporation (NASDAQ: UTHR) today announced receipt of a Paragraph IV Certification Notice Letter on February 3, 2012 from Sandoz Inc. (Sandoz) advising that Sandoz has submitted an Abbreviated New Drug Application (ANDA) to ...

An undisclosed drugmaker is seeking FDA marketing approval for a generic version of United Therapeutics' best-seller Remodulin, which treats pulmonary arterial hypertension. The application includes a claim of invalidity or non-infringement of Remodulin ...

Yahoo! Answers: Search for

Yahoo! Answers: Search for

It is unpleasant to use oxygen with the cord strapped around your face. So then will I be able to breathe better after using remodulin, so that I will not have to use oxygen 24 hours daily?

while taking remodulin, i'm loosing a lot of weight

Loading

Share Your Remodulin Experience

PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider.We hope you found our information about b>Remodulin. About Remodulin : Latest News, Updates, Risks and Benefits